PLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with ...

I reiterate my “Strong Buy” rating on Veeva Systems Inc. with a one-year target price of $275 per share due to strong CRM migration and margin improvement. Veeva reported 14.3% revenue growth ...

Veeva Systems (VEEV) closed the most recent trading day at $224.14, moving +1.43% from the previous trading session. This move lagged the S&P 500's daily gain of 1.59%. Elsewhere, the Dow gained 1 ...